Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![simonseverino Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::108744715.png) Simon Severino | The Sales Booster [@simonseverino](/creator/twitter/simonseverino) on x 2309 followers
Created: 2025-07-21 14:11:06 UTC

CHARLES RIVER LABS 

Charles River Laboratories $CRL could grow XX% quickly. 

Global preclinical research leader trading at cyclical lows with Elliott Management catalyst. 

Serves all top-20 pharma companies, $4B revenue. 

Manufacturing segment spin-off potential unlocks value. 

Is it a buy today? 👇




XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947298293689598043/c:line.svg)

**Related Topics**
[$4b](/topic/$4b)
[$crl](/topic/$crl)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/simonseverino/status/1947298293689598043)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

simonseverino Avatar Simon Severino | The Sales Booster @simonseverino on x 2309 followers Created: 2025-07-21 14:11:06 UTC

CHARLES RIVER LABS

Charles River Laboratories $CRL could grow XX% quickly.

Global preclinical research leader trading at cyclical lows with Elliott Management catalyst.

Serves all top-20 pharma companies, $4B revenue.

Manufacturing segment spin-off potential unlocks value.

Is it a buy today? 👇

XXX engagements

Engagements Line Chart

Related Topics $4b $crl stocks healthcare

Post Link

post/tweet::1947298293689598043
/post/tweet::1947298293689598043